Eagle Seeds And Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 09-11-2024
- Paid Up Capital ₹ 2.99 Cr
as on 09-11-2024
- Company Age 28 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 160.00 Cr
as on 09-11-2024
- Satisfied Charges ₹ 50.74 Cr
as on 09-11-2024
About Eagle Seeds And Biotech
The Corporate was formerly known as Eagle Seeds And Agritech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.99 Cr.
The company currently has active open charges totaling ₹160.00 Cr. The company has closed loans amounting to ₹50.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumangala Jain, Shirish Barwale, Vaibhav Jain, and Three other members serve as directors at the Company.
- CIN/LLPIN
U01409MP1997PTC011544
- Company No.
011544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 1997
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eagle Seeds And Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Jain  | Managing Director | 01-Oct-2005 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shirish Barwale | Director | 16-Jun-2006 | Current |
| Ganpati Nadkarni | Director | 22-Oct-2022 | Current |
| Ajay Vaidya | Director | 07-Dec-2021 | Current |
| Sumangala Jain | Director | 14-Oct-2011 | Current |
| Gulab Singhvi | Director | 23-Dec-2014 | Current |
Financial Performance of Eagle Seeds And Biotech.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eagle Seeds And Biotech?
Unlock access to Eagle Seeds And Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Snipp Interactive (India) Private LimitedActive 9 years 6 monthsGanpati Nadkarni is a mutual person
Maharashtra Hybrid Seeds Company Private LimitedActive 54 years 9 monthsShirish Barwale is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Feb 2024 | ₹40.00 Cr | Open |
Hdfc Bank Limited Creation Date: 13 Feb 2024 | ₹80.00 Cr | Open |
Hdfc Bank Limited Creation Date: 14 Jan 2010 | ₹40.00 Cr | Open |
How Many Employees Work at Eagle Seeds And Biotech?
Unlock and access historical data on people associated with Eagle Seeds And Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eagle Seeds And Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eagle Seeds And Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
